vs
Clearfield, Inc.(CLFD)与Organogenesis Holdings Inc.(ORGO)财务数据对比。点击上方公司名可切换其他公司
Organogenesis Holdings Inc.的季度营收约是Clearfield, Inc.的1.1倍($37.2M vs $34.3M),Clearfield, Inc.同比增速更快(-3.2% vs -57.1%),过去两年Clearfield, Inc.的营收复合增速更高(-3.5% vs -46.5%)
Clearfield, Inc.总部位于美国明尼苏达州明尼阿波利斯市,是一家专注于光纤产品研发生产的企业,其产品主要应用于光纤通信网络建设领域,为通信基础设施部署提供相关硬件支撑。
Organogenesis Holdings Inc.是一家领先的再生医学企业,专注于开发、生产用于伤口护理、外科修复、运动医学和皮肤病领域的先进治疗产品,主要服务美国及部分国际市场的医疗机构与患者,提供经临床验证的医疗解决方案。
CLFD vs ORGO — 直观对比
营收规模更大
ORGO
是对方的1.1倍
$34.3M
营收增速更快
CLFD
高出53.9%
-57.1%
两年增速更快
CLFD
近两年复合增速
-46.5%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $34.3M | $37.2M |
| 净利润 | $-614.0K | — |
| 毛利率 | 33.2% | 30.8% |
| 营业利润率 | -5.3% | -185.1% |
| 净利率 | -1.8% | — |
| 营收同比 | -3.2% | -57.1% |
| 净利润同比 | 67.8% | — |
| 每股收益(稀释后) | $-0.04 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CLFD
ORGO
| Q1 26 | — | $37.2M | ||
| Q4 25 | $34.3M | $225.6M | ||
| Q3 25 | $23.4M | $150.9M | ||
| Q2 25 | $49.9M | $101.0M | ||
| Q1 25 | $47.2M | $86.7M | ||
| Q4 24 | $29.7M | $126.7M | ||
| Q3 24 | $5.6M | $115.2M | ||
| Q2 24 | $48.8M | $130.2M |
净利润
CLFD
ORGO
| Q1 26 | — | — | ||
| Q4 25 | $-614.0K | $43.7M | ||
| Q3 25 | $-9.1M | $21.6M | ||
| Q2 25 | $1.6M | $-9.4M | ||
| Q1 25 | $1.3M | $-18.8M | ||
| Q4 24 | $-1.9M | $7.7M | ||
| Q3 24 | — | $12.3M | ||
| Q2 24 | $-447.0K | $-17.0M |
毛利率
CLFD
ORGO
| Q1 26 | — | 30.8% | ||
| Q4 25 | 33.2% | — | ||
| Q3 25 | 53.2% | — | ||
| Q2 25 | 30.5% | — | ||
| Q1 25 | 30.1% | 72.6% | ||
| Q4 24 | 29.2% | 75.5% | ||
| Q3 24 | — | 76.7% | ||
| Q2 24 | 21.9% | 77.6% |
营业利润率
CLFD
ORGO
| Q1 26 | — | -185.1% | ||
| Q4 25 | -5.3% | 28.1% | ||
| Q3 25 | 10.3% | 13.7% | ||
| Q2 25 | 3.0% | -12.5% | ||
| Q1 25 | 0.6% | -30.9% | ||
| Q4 24 | -6.9% | 8.1% | ||
| Q3 24 | — | 5.4% | ||
| Q2 24 | -4.7% | -10.7% |
净利率
CLFD
ORGO
| Q1 26 | — | — | ||
| Q4 25 | -1.8% | 19.4% | ||
| Q3 25 | -38.8% | 14.3% | ||
| Q2 25 | 3.2% | -9.3% | ||
| Q1 25 | 2.8% | -21.7% | ||
| Q4 24 | -6.4% | 6.1% | ||
| Q3 24 | — | 10.7% | ||
| Q2 24 | -0.9% | -13.1% |
每股收益(稀释后)
CLFD
ORGO
| Q1 26 | — | — | ||
| Q4 25 | $-0.04 | $0.31 | ||
| Q3 25 | $-0.65 | $0.11 | ||
| Q2 25 | $0.11 | $-0.10 | ||
| Q1 25 | $0.09 | $-0.17 | ||
| Q4 24 | $-0.13 | $0.05 | ||
| Q3 24 | — | $0.09 | ||
| Q2 24 | $-0.04 | $-0.13 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $96.4M | $91.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $249.7M | — |
| 总资产 | $268.1M | $520.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
CLFD
ORGO
| Q1 26 | — | $91.4M | ||
| Q4 25 | $96.4M | $93.7M | ||
| Q3 25 | $106.0M | $63.7M | ||
| Q2 25 | $117.2M | $73.1M | ||
| Q1 25 | $112.0M | $110.0M | ||
| Q4 24 | $113.0M | $135.6M | ||
| Q3 24 | $129.0M | $94.3M | ||
| Q2 24 | $123.8M | $89.9M |
总债务
CLFD
ORGO
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $2.2M | $62.3M | ||
| Q2 24 | $2.1M | $63.8M |
股东权益
CLFD
ORGO
| Q1 26 | — | — | ||
| Q4 25 | $249.7M | $300.1M | ||
| Q3 25 | $256.2M | $255.1M | ||
| Q2 25 | $264.5M | $233.2M | ||
| Q1 25 | $265.9M | $242.9M | ||
| Q4 24 | $267.4M | $262.9M | ||
| Q3 24 | $275.8M | $278.5M | ||
| Q2 24 | $274.6M | $263.5M |
总资产
CLFD
ORGO
| Q1 26 | — | $520.0M | ||
| Q4 25 | $268.1M | $598.7M | ||
| Q3 25 | $306.2M | $509.8M | ||
| Q2 25 | $314.7M | $461.1M | ||
| Q1 25 | $310.9M | $467.4M | ||
| Q4 24 | $303.2M | $497.9M | ||
| Q3 24 | $315.3M | $446.3M | ||
| Q2 24 | $318.1M | $443.2M |
负债/权益比
CLFD
ORGO
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.01× | 0.22× | ||
| Q2 24 | 0.01× | 0.24× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-1.4M | — |
| 自由现金流经营现金流 - 资本支出 | $-2.4M | — |
| 自由现金流率自由现金流/营收 | -7.1% | — |
| 资本支出强度资本支出/营收 | 2.9% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
CLFD
ORGO
| Q1 26 | — | — | ||
| Q4 25 | $-1.4M | $39.4M | ||
| Q3 25 | — | $3.1M | ||
| Q2 25 | $7.9M | $-32.9M | ||
| Q1 25 | $3.0M | $-19.9M | ||
| Q4 24 | $7.2M | $10.9M | ||
| Q3 24 | $22.2M | $8.7M | ||
| Q2 24 | $4.0M | $4.7M |
自由现金流
CLFD
ORGO
| Q1 26 | — | — | ||
| Q4 25 | $-2.4M | $34.8M | ||
| Q3 25 | — | $844.0K | ||
| Q2 25 | $7.5M | $-36.5M | ||
| Q1 25 | $654.0K | $-23.6M | ||
| Q4 24 | $5.1M | $7.6M | ||
| Q3 24 | $18.2M | $6.1M | ||
| Q2 24 | $2.8M | $2.9M |
自由现金流率
CLFD
ORGO
| Q1 26 | — | — | ||
| Q4 25 | -7.1% | 15.4% | ||
| Q3 25 | — | 0.6% | ||
| Q2 25 | 15.1% | -36.1% | ||
| Q1 25 | 1.4% | -27.2% | ||
| Q4 24 | 17.1% | 6.0% | ||
| Q3 24 | 323.0% | 5.3% | ||
| Q2 24 | 5.8% | 2.2% |
资本支出强度
CLFD
ORGO
| Q1 26 | — | — | ||
| Q4 25 | 2.9% | 2.1% | ||
| Q3 25 | 2.0% | 1.5% | ||
| Q2 25 | 0.8% | 3.6% | ||
| Q1 25 | 5.1% | 4.2% | ||
| Q4 24 | 7.0% | 2.7% | ||
| Q3 24 | 71.4% | 2.2% | ||
| Q2 24 | 2.5% | 1.4% |
现金转化率
CLFD
ORGO
| Q1 26 | — | — | ||
| Q4 25 | — | 0.90× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | 4.93× | — | ||
| Q1 25 | 2.30× | — | ||
| Q4 24 | — | 1.43× | ||
| Q3 24 | — | 0.71× | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图